脑出血幸存者合并心房颤动的心脑血管事件风险:一项全国性队列研究
该研究基于丹麦卒中登记库,纳入2003至2018年间1885例新发脑出血合并心房颤动的患者,应用PRESTIGE-AF试验的主要纳入与排除标准。随访一年发现,未暴露于口服抗凝药的患者中复发性脑出血、脑血管缺血事件和全因死亡累积发生率分别为1.5%、3.2%和30.3%;启动或恢复口服抗凝药的患者分别为2.8%、3.2%和22.0%。
要点
- 脑出血合并房颤幸存者1年内全因死亡累积发生率达30.3%(未抗凝组)和22.0%(抗凝组),风险极高。
- 脑血管缺血事件(N=63)多于复发性脑出血(N=40),提示缺血风险不容忽视。
- 抗凝组复发性脑出血累积发生率为2.8%,未抗凝组为1.5%,缺血事件两组均为3.2%。
核心结论
- 脑出血合并心房颤动幸存者1年内脑血管缺血事件风险高,全因死亡风险极高。
- 需等待正在进行的临床试验结果以确定此类患者的最佳卒中预防治疗。
研究设计与样本
- 利用丹麦卒中登记库识别2003至2018年间新发脑出血且合并心房颤动的患者,并应用PRESTIGE-AF试验的主要纳入与排除标准。
- 共纳入1885例患者,中位年龄80.0岁,女性占47.6%。
- 随访1年,观察复发性脑出血、脑血管缺血事件和全因死亡的累积发生率。
主要发现
- 共观察到191例脑血管事件和650例全因死亡,其中脑血管缺血事件(N=63)多于复发性脑出血(N=40)。
- 未暴露于口服抗凝药的患者中,复发性脑出血、脑血管缺血事件和全因死亡的累积发生率分别为1.5%、3.2%和30.3%。
- 启动或恢复口服抗凝药的患者中,复发性脑出血、脑血管缺血事件和全因死亡的累积发生率分别为2.8%、3.2%和22.0%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In patients with intracerebral hemorrhage (ICH) and prevalent atrial fibrillation (AF), the optimal stroke prevention strategy is unclear. We sought to estimate the risk of cerebrovascular events among ICH survivors with AF. METHODS: We used the Danish Stroke Registry to identify patients with incident ICH and prevalent AF between 2003 and 2018. Key inclusion/exclusion criteria of the PRESTIGE-AF (Prevention of Stroke in Intracerebral hemorrhage Survivors With Atrial Fibrillation) trial were applied. Cumulative incidence of recurrent ICH, cerebrovascular ischemic event, and all-cause death were investigated after one year. RESULTS: A total of 1885 patients (median age 80.0 years; 47.6% females) were included in the study. We observed 191 cerebrovascular events and 650 all-cause deaths, and more cerebrovascular ischemic events (N=63) than recurrent ICH events (N=40). Risks of recurrent ICH, cerebrovascular ischemic event, and all-cause death were 1.5%, 3.2%, and 30.3%, respectively, among patients not exposed to OAC during follow-up. The cumulative incidences were 2.8% for recurrent ICH, 3.2% for cerebrovascular ischemic events, and 22.0% for all-cause death among patients initiating/resuming OAC during follow-up. CONCLUSIONS: We observed a high risk of cerebrovascular ischemic events and a very high risk of all-cause death at one year after the incident ICH. The results of ongoing clinical trials are warranted to determine optimal stroke prevention treatment among ICH survivors with concomitant AF.
引用
- Nielsen PB, Melgaard L, Overvad TF, et al. Risk of Cerebrovascular Events in Intracerebral Hemorrhage Survivors With Atrial Fibrillation: A Nationwide Cohort Study. Stroke. 2022. PMID: 35414198. doi:10.1161/STROKEAHA.121.038331
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。